Twenty-one-gene recurrence score assay inBRCA-associated versus sporadic breast cancers: Differences based on germline mutation status-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Twenty-one-gene recurrence score assay inBRCA-associated versus sporadic breast cancers: Differences based on germline mutation status

Published:2016-02-09 Issue:8 Volume:122 Page:1178-1184
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Shah Payal D.¹,Patil Sujata²,Dickler Maura N.³,Offit Kenneth⁴,Hudis Clifford A.³,Robson Mark E.³⁴

Affiliation:

1. Abramson Cancer Center; University of Pennsylvania; Philadelphia Pennsylvania

2. Epidemiology and Biostatistics; Memorial Sloan Kettering Cancer Center; New York New York

3. Breast Medicine Service; Memorial Sloan Kettering Cancer Center; New York New York

4. Clinical Genetics Service; Memorial Sloan Kettering Cancer Center; New York New York

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference22 articles.

1. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality;Domchek;JAMA.,2010

2. Clinical practice. Management of an inherited predisposition to breast cancer;Robson;N Engl J Med.,2007

3. Therapeutic approaches for women predisposed to breast cancer;Nathanson;Annu Rev Med.,2011

4. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial;Tutt;Lancet.,2010

5. Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation;Kaufman;J Clin Oncol.,2015

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers;Annals of Oncology;2024-09

2. Clinical characteristics, treatment patterns, and outcomes in adult patients with germline BRCA1/2-mutated, HER2-negative advanced breast cancer: a retrospective medical record review in the United States;Frontiers in Oncology;2024-05-16

3. BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization;Breast Cancer Research and Treatment;2024-04-03

4. Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients;npj Breast Cancer;2023-11-30

5. Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China;Frontiers in Genetics;2023-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3